Vascular and Endovascular Review (VER) is a bi-annual journal aimed at assisting time-pressured physician to stay abreast of key advances and opinion in the vascular and endovascular sphere. VER provides comprehensive update on a range of pertinent issues to support physicians in continuously developing their knowledge and effectiveness in day-to-day clinical practice.
Led by Editor-in-Chief Mr Stephen Black, along with Section Editors: Mr Michael Lichtenberg (Peripheral Artery Disease), Mr Andrew Choong (Aortic), Mr Sebastian Debus (Update of New Literature), Mr Rick de Graaf (Venous) and Mr Ashish Patel (Case Reports) and an editorial board of world-renowned physicians, VER comprises peer-reviewed articles that aim to provide timely updates on the most pertinent issues in the field.
For further information please read our journal information pack. For information on submitting an article, please contact the Managing Editor: firstname.lastname@example.org
Frequency: Bi-annual (spring and autumn); ePub ahead of print throughout the year.
Print ISSN: 2516-3299 Online ISSN: 2516-3302
Aims and Scope
VER aims to assist time-pressured physicians to keep abreast of key advances and opinion in the vascular and endovascular area.
VER comprises balanced and comprehensive articles written by leading authorities. The journal provides comprehensive updates on a range of salient issues to support physicians in continuously developing their knowledge and effectiveness in day-to-day clinical practice.
The journal endeavours, through its timely teaching reviews, to support the continuous medical education of both specialist and general vascular and endovascular surgeons and disseminate knowledge of the field to the wider vascular and endovascular community.
Structure and Format
The journal consists of review articles and editorials. The structure and degree of coverage assigned to each category of the journal is the decision of the Editor-in-Chief, with the support of the Section Editors and Editorial Board. Articles are fully referenced, providing a comprehensive review of existing knowledge and opinion.
VER is guided by overall direction from the Editor-in-Chief, supported by Section Editors and an Editorial Board.
VER’s contributors are recognised authorities in their respective fields.
Peer review is conducted by members of the journal’s Peer Review Board and other experts appointed for their experience and knowledge of a specific topic.
VER is supported by an experienced team of Editors and Technical Editors.
On submission, all articles are assessed by the Editor-in-Chief or Managing Editor to determine their suitability for inclusion.
The Managing Editor, following consultation with the Editor-in-Chief, Section Editors and/or a member of the Editorial Board, sends the manuscript to members of the Peer Review Board, who are selected on the basis of their specialist knowledge in the relevant area. All peer review is conducted double-blind.
Following review, manuscripts are either accepted without modification or accepted pending modification, in which case the manuscripts are returned to the author(s) to incorporate required changes or rejected outright. The Editor-in-Chief reserves the right to accept or reject any proposed amendments.
Once the authors have amended a manuscript in accordance with the reviewers’ comments, the manuscript is returned to the reviewers to ensure the revised version meets their quality expectations. Once approved, the manuscript is sent to the Editor-in-Chief for final approval prior to publication.
Submissions and Instructions to Authors
Contributors are identified by the Editor-in-Chief with the support of the Section Editors and Managing Editor, and guidance from the Editorial Board.
Following acceptance of an invitation, the authors and Managing Editor, in conjunction with the Editor-in-Chief, formalise the working title and scope of the article.
Subsequently, the Managing Editor provides an ‘Instructions to Authors’ document and additional submission details.
The journal is always keen to hear from leading authorities wishing to discuss potential submissions. Please contact the Managing Editor for further details: email@example.com or view the Information for Authors.
Our funding model
Currently, Radcliffe Vascular provides free educational content to cardiologists and allied healthcare professionals. The vast majority of our content is editorially independent, developed at our own cost.
However, to keep the platform a free resource, from time to time we do collaborate and receive funding from select industry partners in the following ways; all sources of such funding are fully declared on all these materials:
- Print and eBook adverts at the front and back of the journals (never within the journal text).
- Web banner advertising.
- Interstitial adverts.
- Pre-roll video adverts (as precursors to our independent content).
- Promotional/supplemental content (published as supplements to our peer-reviewed journals).
- Supported webinars, roundtable discussions, video interviews and live cases.
- Continuing Medical Education (CME) activities.
Open Access, Copyright and Permission
Articles published within this journal are open access, which allows users to copy, redistribute and make derivative works for non-commerical purposes, provided the original work is cited correctly. The author retains all non-commerical rights for articles published under the CC-BY-NC 4.0 license.
Radcliffe Vascular retains all commerical rights for articles herein unless otherwise stated. Permission to reproduce an article or any of its contents for commerical purposes, either in full or in part, should be sought from the publication's Managing Editor.
Authors are responsible for obtaining permission for all copyright material, including tables, figures and images. Evidence will need to be provided where permission has been granted upon request.
To support open access publication costs, Radcliffe Vascular charge an Article Publication Charge (APC) to authors upon acceptance of an unsolicited paper as follows: £525.00 UK | €595.00 Eurozone | $665.00 all other countries.
(Submissions from the UK will be subject to the current UK VAT charge. A VAT registration number should be supplied to ensure any invoice accounts for VAT at your local relevant rate. Those not registered for VAT will have VAT added.)
APC Waivers and Discounts
A 100% waiver is available for all papers which are solicited directly from Radcliffe Vascular.
Authors from low-income countries as defined by the World Bank are eligible for a full waiver of the APC charge. Authors from middle-income countries are eligible for a 50% waiver. Discretionary waivers may also be considered.
Radcliffe Vascular remains dedicated to helping researchers to disseminate scientific information globally and is actively working to partner with individual institutions to offer full or partial APC discounts. Institutional agreements will be listed here. If you are an institution looking to partner with us, or think your institution should, then please contact the Publishing Director.
To ensure editorial integrity, the waiver process is not handled by the journal Managing Editors. Authors should submit a waiver request during the electronic submission process.
All articles included in Vascular and Endovascular Journal are available as reprints (minimum order 1,000). Please contact Rob Barclay at firstname.lastname@example.org
Distribution and Readership
VER is distributed bi-annually through controlled circulation to general and specialist senior vascular and endovascular professionals in Europe. All manuscripts published in the journal are free-to-access online.
Copyright and Permission
Radcliffe Vascular is the sole owner of all articles and other materials that appear in VER unless otherwise stated. Permission to reproduce any part of an article should be sought from the journal’s Managing Editor.